Jul 2, 2026 04:19AM
Jun 25, 2026 04:01PM
Jun 25, 2026 04:01PM
Jun 23, 2026 04:40AM
Jun 22, 2026 08:00AM
Jun 22, 2026 08:00AM
May 6, 2026 08:00AM Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
Apr 27, 2026 05:21PM
Apr 27, 2026 05:21PM
Apr 6, 2026 06:41AM
Mar 25, 2026 07:22AM
Mar 19, 2026 01:54PM
Mar 19, 2026 08:00AM
Jan 6, 2026 10:31AM Raymond James on Taysha Gene Therapies (TSHA): 'Continued Regulatory Progress For TSHA-102; Remain Strong Buy Rated'
Jan 6, 2026 08:02AM
Jan 6, 2026 08:00AM
Dec 4, 2025 05:08AM
Nov 5, 2025 05:11AM
Nov 4, 2025 07:00AM
Oct 20, 2025 04:10PM
Oct 16, 2025 04:02PM Taysha Gene Therapies regains full rights to TSHA-102 Rett syndrome program
Oct 16, 2025 04:01PM
Oct 9, 2025 08:00AM
Oct 9, 2025 08:00AM
Oct 2, 2025 01:04PM
Oct 2, 2025 08:00AM
Oct 2, 2025 08:00AM
Sep 12, 2025 04:11AM Citizens JMP Reiterates Market Outperform Rating on Taysha Gene Therapies (TSHA)
Aug 12, 2025 08:01AM
Jul 11, 2025 06:37AM
Jun 3, 2025 05:26PM
Jun 3, 2025 05:17PM
May 29, 2025 04:12AM
May 28, 2025 04:01PM
May 28, 2025 04:01PM Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult/Adoles
May 15, 2025 03:33PM
May 15, 2025 08:00AM
Feb 26, 2025 08:00AM
Jan 6, 2025 02:00PM
Nov 15, 2024 07:07AM
Nov 13, 2024 04:01PM
Oct 22, 2024 08:00AM Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress
Sep 26, 2024 08:00AM
Aug 12, 2024 08:01AM
Jun 18, 2024 07:30AM
Jun 18, 2024 07:30AM
May 14, 2024 04:01PM
May 14, 2024 03:10AM
May 2, 2024 08:00AM Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
Mar 19, 2024 04:01PM

325,693 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All